Bath salts abuse leading to new-onset psychosis and potential for violence

Clinical Schizophrenia and Related Psychoses

Volumn 11, Issue 2, 2017, Pages 120-124

  John, Michelle E ^a   Thomas Rozea, Crystal ^a   Hahn, David ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Bath salts; MDPV; Mephedrone; Synthetic cathinones

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; DESIGNER DRUG; STREET DRUG;

ADULT; CASE REPORT; DRUG DEPENDENCE; HUMAN; LEGISLATION AND JURISPRUDENCE; MALE; PSYCHOSES, SUBSTANCE-INDUCED; PUBLIC HEALTH; UNITED STATES; VIOLENCE;

ADULT; DESIGNER DRUGS; HUMANS; MALE; PSYCHOSES, SUBSTANCE-INDUCED; PUBLIC HEALTH; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; SYMPATHOMIMETICS; UNITED STATES; VIOLENCE;

EID: 85027974899     PISSN: 19351232     EISSN: 19412010     Source Type: Journal    
DOI: 10.3371/CSRP.JORO.061314     Document Type: Article

References (34)

1. Winder GS, Stern N, Hosanager A. Are "bath salts" the next generation of stimulant abuse? J Subst Abuse Treat 2013; 44(1): 42-45.
2. Prosser JM, Nelson LS. The toxicology of bath salts: A review of synthetic cathinones. J Med Toxicol 2012; 8(1): 33-42.
3. Jerry J, Collins G, Streem D. Synthetic legal intoxicating drugs: The emerging 'incense' and 'bath salts' phenomenon. Cleve Clin J Med 2012; 79(4): 258-264.
4. Watterson LR, Kufahl PR, Nemirovsky N, Sewalia K, Grabenauer M, Thomas BF, et al. Potent rewarding and reinforcing effects of synthetic cathinone 3,4-methyle-nedioxypyrovalerone(MDPV). Addict Biol 2013; 19(2): 165-174.
5. Kyle PB, Iverson RB, Gajagowni RG, Spencer L. Illicit bath salts: Not for bathing. J Miss State Med Assoc 2011; 52(12): 375-377.
6. Fass JA, Fass AD, Garcia AS. Synthetic cathinones (bath salts): Legal status and patterns of abuse. Ann Pharmacolther 2012; 46(3): 436-441.
7. Gershman JA, Fass AD. Synthetic cathinones ('bath salts'): Legal and healthcare challenges. P T 2012; 37(10): 571-595.
8. Murphy CM, Dulaney AR, Beuhler MC, Kacinko S. "Bath salts" and "plant food" products: The experience of one regional US poison center. J Med Toxicol 2013; 9(1): 42-48.
9. Murray BL, Murphy CM, Beuhler MC. Death following recreational use of designer drug "bath salts" containing 3,4-methylenedioxypyrovalerone (MDPV). J Med Toxicol 2012; 8(1): 69-75.
10. Coppola M, Mondola R. 3,4-methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol Lett 2012; 208(1)5: 12-15.
11. Ross EA, Watson M, Goldberger B. "Bath salts" intoxication. N Engl J Med 2011; 365(10): 967-968.
12. Kadaria D, Sinclair SE. A case of acute agitation with a negative urine drug screen: A new wave of "legal" drugs of abuse. Tenn Med 2012; 105(9): 31-32.
13. Stoica MV, Felthous AR. Acute psychosis induced by bath salts: A case report with clinical and forensic implications. J Forensic Sci 2013; 58(2): 530-533.
14. Antonowicz JL, Metzger AK, Ramanujam SL. Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: Two cases. Gen Hosp Psychiatry 2011; 33(6): 640.e5-6.
15. Sharma TR, Iskandar JW, Ali R, Shah UR. Bath salt-induced delirium and brief psychotic episode in an otherwise healthy young man. Prim Care Companion CNS Disord 2012; 14(2). pii: PCC.11101224.
16. Center for Disease Control and Prevention (CDC). Emergency department visits after use of a drug sold as "bath salts"-Michigan, November 13, 2010-March 31, 2011. MMWR Morb Mortal Wkly Rep 2011; 60(19): 624-627.
17. Lajoie TM, Rich A. "Bath salts": A new drug epidemic-A case report. Am J Addict 2012; 21(6): 572-573.
18. Caffery T, Musso M, Manausa R, Everett J, Perret J. Riding high on cloud 9. J LA State Med Soc 2012; 164(4): 186-189.
19. Olives TD, Orozco BS, Stellpflug SJ. Bath salts: The ivory wave of trouble. West J Emerg Med 2012; 13(1): 58-62.
20. Gallucci G, Malik M, Khan S, Agzal N, Trimzi I. Bath salts: An emerging danger. Del Med J 2011; 83(11): 357-359.
21. Russo R, Marks N, Morris K, King H, Gelvin A, Rooney R. Life-threatening necrotizing fasciitis due to 'bath salts' injection. Orthopedics 2012; 35(1): E124-e127.
22. Joksovic P, Mellos N, van Wattum JV, Chiles C. "Bath salts-induced psychosis and serotonin toxicity. J Clin Psychiatry 2012; 73(8): 1125.
23. Striebel JM, Pierre JM. Acute psychotic sequelae of "bath salts". Schizophr Res 2011; 133(1-3): 259-260.
24. Gorriti MA, Rodríguez de Fonseca F, Navarro M, Palomo T. Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats. Eur J Pharmacol1999; 365(2-3): 133-142.
25. Mangewala V, Sanwar SR, Shah K, Singh T. Bath salts-induced psychosis: A case report. Innov Clin Neurosci 2013; 10(2): 10-11.
26. Thornton SL, Gerona RR, Tomaszewski CA. Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine and product quantification. J Med Toxicol 2013; 8(3): 310-313.
27. Penders TM, Lang MC, Pagano JJ, Gooding ZS. Electroconvulsive therapy improves persistent psychosis after repeated use of methylenedioxypyrovalerone ("bath salts"). J ECT 2013; 29(4): E59-60.
28. Penders TM, Gestring R. Hallucinatory delirium following MDPV: "bath salts". Gen Hosp Psychiatry 2011; 33(5): 525-526.
29. Kasick DP, McKnight CA, Klisovic E. "Bath salt" ingestion leading to severe intoxication delirium: Two cases and brief review of emergence of mephedrone use. Am J Drug Alcohol Abuse 2012; 38(2): 176-180.
30. Penders TM, Gestring RE, Vilensky DA. Intoxicated delirium following use of synthetic cathinone derivatives. Am J Drug Alcohol Abuse 2012; 38(6): 616-617.
31. Penders TM, Gestring RE, Vilensky DA. Excited delirium following use of synthetic cathinones (bath salts). Gen Hosp Psychiatry 2012; 34(6): 647-650.
32. Dehner N, Rowley S. Sub. House Bill 64 Spice/K2, Bath Salts. Office of Criminal Justice Services. http: //www.ocjs.ohio.gov/hb64-bathsaltsspice.pdf
33. New Law Bans Bath Salts in Ohio. http: //blog.criminalattorneycolumbus.com/2011/10/24/new-law-bans-bath-salts-in-ohio/
34. Leonhart MM. Rule 2013 United States Department of Justice Drug Enforcement Adminstration Office of Diversion Control, Federal Register 2013; 78( 3). http: //www.deadiversion.usdoj.gov/fed-regs/rules/2013/fr0104.htm